Raymond James Sees Marathon Stock Poised for 270 Target
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
Learn the scenarios where index funds outperform target date funds, with emphasis on fees, control, and asset allocation flexibility.
26,348 articlesRaymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
A look at why tqqq holders face risk that extends beyond Nasdaq direction, as daily resets and market swings bite lev...
When a chief financial officer sells a sizable stake, investors take notice. This article breaks down Shoals Technolo...
Space etfs skyrocketing ahead signal excitement about space tech, but public market exposure comes with unique risks....
A legendary TV send-off isn’t just about drama. It exposes the hidden costs of chaos—how budgets, insurance, and risk...
As bond yields drift, investors are eyeing dividend ETFs that could replace bond income in 2026. Learn how three top ...
Young earners face a tough choice: invest now or aggressively repay debt. This report explains the math, the Baby Ste...
A quarterly data snapshot reveals moves by the wealthiest fund managers. This piece dives into why these billionaire ...
As markets navigate mid-2026 volatility, investors weigh broad global exposure inside Roth IRAs. VT offers tax-free g...
Strong friendships among women go beyond looks and style. This article explores what women appreciate most in each ot...
Despite a modest headline fee, the SPDR S&P Semiconductor ETF trails cheaper rivals on longer horizons, signaling a h...
A blockbuster IP can be a boon for investors, but rumors and production hiccups can tilt risk into your wallet. Here’...